Antithrombotic treatment in ischemic cerebrovascular disease.
Tohgi
H
H
The Department of Neurology, Iwate Medical University, Uchimaru, Morioka.
Takahashi
H
H
Utsugisawa
K
K
Sasaki
K
K
D001281:Atrial Fibrillation / Q000150:complications; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012008:Recurrence; D013925:Thromboplastin / Q000235:genetics / Q000378:metabolism; D014841:von Willebrand Factor / Q000235:genetics / Q000378:metabolism
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014841:von Willebrand Factor; D013925:Thromboplastin